Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?

To: BIGFRED who wrote (1862)	10/17/1998 7:05:00 PM
From: Guy.	Read Replies (1) \| Respond to of 4650

Dear Fred,i suspect either i am missing something or we have a misunderstanding. What do you mean by saying <the testing back east>? Which test? The lungcheck results will be out probably by the end of october+ and a PR will come as soon as everything is ready for publish. The only tests that will be done after that will be done as an expanded trial to get an FDA approval(although it is not needed). DARPA,i really hope that the canadian company succeeds,it will be great.But phase3 trials usually takes at least 2 years and till then Biomoda is expected to have its kit distributed all around the world. Biomoda's cure is not expected to be approved so quickly,but as Fred said there is room for several cures and i wish they both will work. Also remember that at the testing segment Biomoda is unique at this stage. Guy

To: BIGFRED who wrote (1862)	10/18/1998 9:22:00 PM
From: DARPA	Read Replies (1) \| Respond to of 4650

Thanks for the note Fred. My condolences on your childrens' illness. Indeed, a painless and effective cure for cancer, once and for all, would be wonderful breakthrough. From an investment standpoint, I would also like to prevent pain and suffering. The longer I stay in this particular (ADOT) investment the more I worry about other technologies beating Biomoda to market, like Neovastat - worse things could happen - and/or this company running out of $$ and/or mismanaging the execution of a successful rollout. I'd prefer to see my fellow ADOT/Biomoda "Netizens" be rewarded for the money and time they have invested in following this start-up. Do you have hard time lines as to when Ari sees key milestones being achieved, and what are his key milestones - specifically the tests back East. Which by the way I had heard about through another poster about a month and a half ago, so I wasn't surprised to hear about it finally from Guy, but delays are frustrating. I'm starting to wonder if they have the appropriate marketeers in place. And my source suggests that Ari has some personal financial troubles of his own. It's hard to perform or negotiate with confidence when you're financially up the creek. This is a REAL BIG issue with me right now. And if GUY is the extent of our international licensing and marketing organization then the biggest challenges are ahead of this company. A 60 Minutes or 20/20 peice would help right about now. What about the Journal of American Medicine? A peice in their would be helpfull as well. But, ultimately, it's going to take some serious dollars and investment in sales and marketing to get the critical mass behind the procedure, assuming of course the test results are flawless.